How Civil Society Organisations Changed the Regulation of Clinical Trials in India

In 2005 India changed its pharmaceutical and innovation policy that facilitated a dramatic increase in international clinical trials involving study sites in India. This policy shift was surrounded by controversies; civil society organisations (CSOs) criticised the Indian government for promoting th...

Descripción completa

Detalles Bibliográficos
Autores principales: Sariola, Salla, Jeffery, Roger, Jesani, Amar, Porter, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636898/
https://www.ncbi.nlm.nih.gov/pubmed/31391707
http://dx.doi.org/10.1080/09505431.2018.1493449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636898/
https://www.ncbi.nlm.nih.gov/pubmed/31391707
http://dx.doi.org/10.1080/09505431.2018.1493449

Ejemplares similares